Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$154.64 USD
+0.36 (0.23%)
Updated May 17, 2024 04:00 PM ET
After-Market: $155.00 +0.36 (0.23%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/18/2024
Time: -- |
6/2024 | $2.74 | -0.50% |
Earnings Summary
For their last quarter, Johnson & Johnson (JNJ) reported earnings of $2.71 per share, beating the Zacks Consensus Estimate of $2.64 per share. This reflects a positive earnings surprise of 2.65%. Look out for JNJ's next earnings release expected on July 18, 2024. For the next earning release, we expect the company to report earnings of $2.74 per share, reflecting a year-over-year decrease of 2.14%.
Earnings History
Price & Consensus
Zacks News for JNJ
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services